Symptoms of CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A Genetic Test
Bare Lymphocyte Syndrome Type 2 (BLS2), specifically the complementation group A, is a rare and severe genetic disorder that affects the immune system. This condition is characterized by a mutation in the CIITA gene, which plays a crucial role in the immune response by regulating the expression of major histocompatibility complex (MHC) class II genes. Individuals with mutations in the CIITA gene suffer from a range of symptoms stemming from their compromised immune systems.
The primary symptoms associated with CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A include recurrent respiratory infections, which can be severe and lead to chronic lung disease. Patients often present with bronchitis, pneumonia, and other respiratory ailments from a young age. Due to the compromised immune system, these infections can be difficult to treat and may recur frequently.
In addition to respiratory issues, individuals with this condition may experience gastrointestinal problems, including diarrhea and malabsorption, which can lead to failure to thrive in infants and weight loss in older children and adults. The skin can also be affected, with some patients developing severe dermatitis.
Another significant concern is the increased risk of autoimmune disorders and malignancies, particularly those related to the lymphatic system, such as lymphoma. The immune system’s inability to function properly can lead to an increased risk of developing autoimmune conditions, where the body’s immune system attacks its own tissues.
Given the severity of the symptoms and the potential for life-threatening complications, early diagnosis and management of CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A are crucial. This is where genetic testing plays a vital role.
CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A Genetic Test
DNA Labs UAE offers a comprehensive genetic test for diagnosing CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A. This test is crucial for confirming the diagnosis, which can then guide appropriate treatment and management strategies. The test involves analyzing the patient’s DNA to identify mutations in the CIITA gene that are responsible for the condition.
The cost of the CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A Genetic Test at DNA Labs UAE is 4400 AED. While the cost may seem significant, it is essential to consider the value of an accurate diagnosis. Early and precise identification of the condition can enable tailored treatment plans, potentially reducing the frequency and severity of infections and other complications associated with the syndrome.
For more information about the CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A Genetic Test and to schedule a test, please visit DNA Labs UAE.
Conclusion
Bare Lymphocyte Syndrome Type 2 Complementation Group A is a serious condition that requires prompt and accurate diagnosis for effective management. The symptoms associated with the CIITA gene mutation are varied and can significantly impact the quality of life. With the genetic testing services provided by DNA Labs UAE, individuals suspected of having this condition can receive a definitive diagnosis, which is the first step towards managing the symptoms and improving outcomes. By investing in the CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A Genetic Test, patients and their families can access crucial information that will help guide their healthcare decisions and treatment plans.
